Skip to content
All Sections
Subscribe Now
50°F
Friday, November 22nd 2024
e-Edition
Home Page
Close Menu
News
News
Crime and Public Safety
Investigative Reporting
Election
Politics
Health
Environment
Business
Best Reviews
Housing
Jobs
Local News
Local News
Long Beach
Los Angeles
Los Angeles County
Sports
Sports
High School Sports
Chargers
Rams
Lakers
Clippers
Dodgers
Angels
College Sports
UCLA Sports
USC Sports
Long Beach State sports
Kings
Ducks
Olympics
Boxing/MMA
Soccer
Horse Racing
Things To Do
Things To Do
Restaurants Food and Drink
Movies
Music + Concerts
Theater
TV and Streaming
Home + Garden
Travel
Amusement Parks
Comics
Puzzles
Events
Obituaries
Obituaries
News Obituaries
Place an Obituary
Opinion
Opinion
Editorials
Opinion Columns
Commentary
Letters to the Editor
Editorial Board
Endorsements
The Grunion
The Grunion
News
Education
Sports
Things to Do
Opinion
E-Edition
Advertising
Contact Us
SCNG Premium
Sponsored Content
The T.E.A.
Subscribe
Press-Telegram Store
Log In
Logout
Close Menu
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Account Settings
Contact Us
Log Out
Spoof a user
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Search
Press Telegram
50°F
Friday, November 22nd 2024
e-Edition
News
Local News
Sports
Things to Do
Obituaries
Opinion
The T.E.A.
Trending:
Live election results
Southwest offering buyouts
Thanksgiving take-out meals ð
8 Disney holiday treats
High School Football
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
58.23
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,106
Open
58.23
Bid (Size)
58.12 (1)
Ask (Size)
58.41 (1)
Prev. Close
58.23
Today's Range
58.23 - 58.23
52wk Range
39.35 - 61.08
Shares Outstanding
2,222,113,553
Dividend Yield
4.12%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is Bristol Myers Squibb Stock a Buy?
November 21, 2024
Via
The Motley Fool
Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
November 21, 2024
Via
The Motley Fool
Performance
YTD
+10.37%
+10.37%
1 Month
+10.37%
+10.37%
3 Month
+22.28%
+22.28%
6 Month
+40.18%
+40.18%
1 Year
+17.83%
+17.83%
More News
Read More
Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms
November 19, 2024
From
Bristol Myers Squibb
Via
Business Wire
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
November 18, 2024
Via
Benzinga
Not-So-Big Pharma
November 16, 2024
Via
Talk Markets
Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 16
November 16, 2024
Via
Talk Markets
Bristol-Myers Faces Renewed $6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issue
November 15, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer
November 15, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Receives Positive CHMP Opinion for Repotrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer and Advanced NTRK-Positive Solid Tumors
November 15, 2024
From
Bristol Myers Squibb
Via
Business Wire
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever
November 15, 2024
Via
The Motley Fool
2 Beaten-Down Dividend Stocks to Buy and Hold
November 14, 2024
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
November 13, 2024
Via
Benzinga
Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
November 13, 2024
Via
Benzinga
Avidity Bio Has Surged 416% This Year — And That's Before Today's 'Game-Changing' News
November 13, 2024
Via
Investor's Business Daily
3 Stocks Seeing Insider Buys: CNC, PFE, BMY
November 12, 2024
Via
Talk Markets
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
November 12, 2024
Via
Benzinga
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 12, 2024
Via
Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
November 12, 2024
Via
Benzinga
What's Going On With Bristol-Myers Squibb Shares Monday?
November 11, 2024
Via
Benzinga
Dow, S&P 500 On Track For Milestone Closes
November 11, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
November 11, 2024
Via
Benzinga
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
November 11, 2024
Via
Benzinga
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
November 11, 2024
Via
Benzinga
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
November 11, 2024
Via
Benzinga
Bristol Myers Rockets 12% After AbbVie's Schizophrenia Drug Fails
November 11, 2024
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close